STI.VI. Study: How to Improve Lifestyles in Screening Contexts (STIVI)
Primary Purpose
Lifestyle Risk Reduction, Weight Changes, Body, Breast Cancer
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Diet group
Physical activity group
Physical activity and diet group
Sponsored by
About this trial
This is an interventional prevention trial for Lifestyle Risk Reduction focused on measuring Breast cancer screening, Colorectal Cancer screening, Primary prevention, Lifestyles, Teachable moment
Eligibility Criteria
Inclusion Criteria:
- 49 to 55-year-old women invited to mammography screening,
- 58 to 61 year-old people (both sexes) invited to colorectal screening
Exclusion Criteria:
- psychiatric disorders,
- disabling disease
- life expectancy <6 months
- eating or deambulation disorders
- in physiotherapy at the time of recruitment.
Sites / Locations
- S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
Active Comparator
Active Comparator
Active Comparator
No Intervention
Arm Label
Diet Group
Physical activity group
Physical activity and diet group
Control group
Arm Description
Outcomes
Primary Outcome Measures
feasibility outcome
initial participation rate overall and stratified by intervention group, age, and gender;
impact of intervention model
compliance to lifestyle recommendations and their maintenance assessed through the STI.VI. questionnaire;
impact of intervention model
changes in anthropometric measurements
impact of intervention model
comparison of metabolic parameters (insulin, glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, IGF-1, testosterone)
impact of intervention model
evaluation of potential genetic and/or metabolic biomarkers in cancer development;
screening-related indicators
screening participation rate in subjects enrolled in the STI.VI. study and, viceversa, STI.VI. participation rate in screened subjects;
screening-related indicators
evaluation of breast and colorectal screening outcomes among STI.VI. participants
Secondary Outcome Measures
Biobank implementation
number of blood sample and saliva sample cryopreserved at baseline and at final follow up
Circulating biomarkers association with breast and colorectal cancer
investigate whether selected circulating miRNAs previously found associated to brast and colorectal risk are significantly altered in the plasma of cancer patients compared to matched healthy controls and if they satisfy pre-specified true- and false positive rates that are considered minimally acceptable in the screening setting.
Full Information
NCT ID
NCT03118882
First Posted
March 31, 2017
Last Updated
April 18, 2017
Sponsor
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Collaborators
Azienda Sanitaria Locale Torino 1
1. Study Identification
Unique Protocol Identification Number
NCT03118882
Brief Title
STI.VI. Study: How to Improve Lifestyles in Screening Contexts
Acronym
STIVI
Official Title
Pilot RCT on Lifestyles Impact on Health Outcomes in the General Population Invited to Mammography and Colorectal Cancer Screening Programmes. (STI.li di VI.ta - Lifestyles) STI.VI.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2017
Overall Recruitment Status
Completed
Study Start Date
May 2010 (undefined)
Primary Completion Date
January 2014 (Actual)
Study Completion Date
June 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Collaborators
Azienda Sanitaria Locale Torino 1
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The main study objective is to determine the feasibility and impact (effectiveness) of intervention models for lifestyle changing (diet and physical activity) on health outcomes. Women 50 to 54-year-old attending the local breast cancer screening and 58-year-old people (both sexes) undergoing colorectal cancer screening are invited to participate in the study. Compliers are randomized into 3 intervention groups (Diet, Physical Activity, and Physical Activity and Diet) and into the 'usual care' Control group. Biological sampling (blood and saliva) is collected from all participants. All participants undergo also anthropometric measurements and fill in a self-administered validated questionnaire on their dietary and physical activity habits. All enrolled subjects receive a booklet with basic information about diet and physical activity. Subjects randomized to the 3 intervention groups are also offered one theoretical and three training courses. The courses are specifically designed for the different interventions proposed and aimed at reinforcing the educational counseling and at supporting behavioral changes.
Follow-up is performed at 8 (intermediate follow-up) and 12-14 (final follow-up) months for repeating anthropometric measurements and questionnaire filling and blood sampling (at the final one).
Detailed Description
The study aims to evaluate the effectiveness of intervention models on diet and physical activity.
The study randomizes eligible subjects into four groups: Diet group, Physical Activity group, Physical Activity and Diet group and "Usual Care" control group. To each group a specific intervention is delivered, consisting of counselling, informative material, and dedicated training.
All participants (with the exception of the control group) receive a basic counselling by field experts. Afterwards they are offered an advanced training including more specific and detailed actions.
An information booklet specifically developed for this study is distributed to all participants. The booklet contains general information on primary prevention, based on the most reliable and updated bibliographic sources on diet and physical exercise.
Together with the letter of screening invitation eligible men and women receive the proposal to participate in the STI.VI. study. Participation to screening is not considered a prerequisite for study participation. A direct phone number and e-mail address are given for extra information.
At the time of screening A screening receptionist asks people who received the STI.VI. invitation (identified through a flag) whether they are interested in the STI.VI. study and therefore refers them to the STI.VI. desk.
At the STI.VI. desk, trained research assistants give further explanations and additional material (patient information sheet, informed consent form and the STI.VI. questionnaire). If informed consent is signed, an appointment is fixed for anthropometric measurements and for taking blood and saliva samples.
People are asked to fill in the questionnaire and to hand it back at the time of the blood sampling.
The STI.VI. questionnaire consists of 5 sections (physical activity, dietary habits, smoking habits, general health conditions, and general information) in order to collect baseline information on lifestyle habits. Type, amount and frequencies of dietary consumptions and physical activities are collected. The questionnaire also investigates the perception of one's own lifestyle and an motivation towards change.
In this study phase all participants are randomly allocated to the 4 study groups.
This is achieved through a permuted block design with block size of 12, 16, and 20 units width (W.F. Rosenberger, J. Lachin. Randomization in clinical trials: theory and practice. Wiley and sons, 2002, pag. 57). This method allows an almost complete uniform distribution of the randomisation groups in every moment of the study; this is necessary in order to simplify the subsequent courses management (see below). Participants are told about their group allocation at the time of biological sampling / anthropometric measurements, only.
At baseline appointment.
Participant subjects undergo anthropometric measurements. The following information are collected:
Reproductive and eventual menopause history (women only)
Eventual drug therapy under way,
Height,
Body composition,
Waist circumference
Arterial pressure. Then participants undergo blood drawing. Two types of blood samples are drawn: one for immediate biochemical analysis and another to be frozen. The freshly blood is used for instantaneous examinations for the following clinic-biochemical parameters: Insulin, Glucose, Total Cholesterol, LDL,HDL, Triglycerides, Minerals (Sodium, Potassium, Calcium, Iron), IGF-I, Testosterone, 17-ß-Estradiol, SHBG. These analyses are made for women invited to mammography screening while for people invited to colorectal screening supplemental tests are made also for vitamin D, 25 OH, PRC and high sensitive PRC.
Cryopreserved blood samples are stored in a bio-bank for epigenetic, metabolomics and metabonomics analyses. Bio-banking includes a security system and a data base specifically implemented for samples storage and traceability.
About 3 ml of saliva are also collected to investigate variations in genetic and metabolic parameters. Saliva samples are cryopreserved with the same modalities as blood samples.
Immediately after biological sampling / anthropometric measurements a short counselling takes place. Trained counsellors answer all eventual questions on the study posed by participants and inform them on the next steps. They also deliver to all participants a basic booklet containing general information on primary prevention, based on the most reliable and updated bibliographic sources on diet and physical exercise (World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: AICR, 2007; WHO, Move for Health, 2002; EU Working Group "Sport and Health", EU Physical Activity Guidelines, 2008).
Follow-up phase
Two follow-ups are planned:
• Intermediate, after 8 months since biological sampling / anthropometric measurements (the exact date is reckoned calculating 6 months + the average intervention duration ± 2 weeks, for managing reasons): it consists of repeating anthropometric measurements and questionnaire filling, and counselling.
All participants are contacted by letter and/or telephone, inviting them to contact the study secretariat in order to fix an appointment for repeating anthropometric measurements and questionnaire filling; during the follow-up visit trained counsellors verify participants' compliance with the provided recommendations, examine eventual encountered difficulties and provide support if needed.
• Final, after 6 months from intermediate follow-up (i.e., after 14 months since biological sampling / anthropometric measurements): it consists of repeating anthropometric measurements, biological sampling, and questionnaire filling, and counselling.
All participants are contacted by letter and/or telephone, inviting them to contact the study secretariat in order to fix an appointment for repeating once again anthropometric measurements, questionnaire filling and also biological sampling.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Lifestyle Risk Reduction, Weight Changes, Body, Breast Cancer, Colorectal Cancer
Keywords
Breast cancer screening, Colorectal Cancer screening, Primary prevention, Lifestyles, Teachable moment
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
1270 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Diet Group
Arm Type
Active Comparator
Arm Title
Physical activity group
Arm Type
Active Comparator
Arm Title
Physical activity and diet group
Arm Type
Active Comparator
Arm Title
Control group
Arm Type
No Intervention
Intervention Type
Behavioral
Intervention Name(s)
Diet group
Intervention Description
A meeting where an expert illustrates the scientific basis of a proper diet. Moreover, clear and practical indications for dietary habits improvement and for suggested food purchase are provided. After having completed the basic module, participants are offered the opportunity of deepening the educational process through an advanced module:hree theoretical and practical cooking meetings (total of 10 hours) held by cooks with an expertise in natural cuisine and by trained dieticians.
Intervention Type
Behavioral
Intervention Name(s)
Physical activity group
Intervention Description
A meeting where an expert illustrates the benefits of a constant PA. Moreover, indications are given on sport opportunities and walking groups in the city organised by public authorities. After having completed the basic module, participants are offered the opportunity of deepening the educational process through an advanced module: three theoretical and practical lessons (total of 10 hours) held by expert physical trainers.
Intervention Type
Behavioral
Intervention Name(s)
Physical activity and diet group
Intervention Description
A meeting where the indications given to the previous groups are presented simultaneously. Particular attention is paid to the interaction between the two activities. After having completed the basic module, participants are offered the opportunity of deepening the educational process through an advanced module: four theoretical and practical meetings (total of 12 hours), two lessons focus on diet and two on PA.
Primary Outcome Measure Information:
Title
feasibility outcome
Description
initial participation rate overall and stratified by intervention group, age, and gender;
Time Frame
14 months
Title
impact of intervention model
Description
compliance to lifestyle recommendations and their maintenance assessed through the STI.VI. questionnaire;
Time Frame
14 months
Title
impact of intervention model
Description
changes in anthropometric measurements
Time Frame
14 months
Title
impact of intervention model
Description
comparison of metabolic parameters (insulin, glucose, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, IGF-1, testosterone)
Time Frame
14 months
Title
impact of intervention model
Description
evaluation of potential genetic and/or metabolic biomarkers in cancer development;
Time Frame
14 months
Title
screening-related indicators
Description
screening participation rate in subjects enrolled in the STI.VI. study and, viceversa, STI.VI. participation rate in screened subjects;
Time Frame
up to 10 years after study end
Title
screening-related indicators
Description
evaluation of breast and colorectal screening outcomes among STI.VI. participants
Time Frame
up to 10 years after study end
Secondary Outcome Measure Information:
Title
Biobank implementation
Description
number of blood sample and saliva sample cryopreserved at baseline and at final follow up
Time Frame
up to 10 years after study end
Title
Circulating biomarkers association with breast and colorectal cancer
Description
investigate whether selected circulating miRNAs previously found associated to brast and colorectal risk are significantly altered in the plasma of cancer patients compared to matched healthy controls and if they satisfy pre-specified true- and false positive rates that are considered minimally acceptable in the screening setting.
Time Frame
up to 10 years after study end
10. Eligibility
Sex
All
Minimum Age & Unit of Time
49 Years
Maximum Age & Unit of Time
61 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
49 to 55-year-old women invited to mammography screening,
58 to 61 year-old people (both sexes) invited to colorectal screening
Exclusion Criteria:
psychiatric disorders,
disabling disease
life expectancy <6 months
eating or deambulation disorders
in physiotherapy at the time of recruitment.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nereo Segnan, MD MSc Epi
Organizational Affiliation
Director
Official's Role
Principal Investigator
Facility Information:
Facility Name
S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino
City
Torino
State/Province
Piedmont
ZIP/Postal Code
10123
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
12729175
Citation
McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003 Apr;18(2):156-70. doi: 10.1093/her/18.2.156.
Results Reference
background
PubMed Identifier
20950640
Citation
Robb KA, Power E, Kralj-Hans I, Atkin WS, Wardle J. The impact of individually-tailored lifestyle advice in the colorectal cancer screening context: a randomised pilot study in North-West London. Prev Med. 2010 Dec;51(6):505-8. doi: 10.1016/j.ypmed.2010.10.002. Epub 2010 Oct 13.
Results Reference
background
PubMed Identifier
23324132
Citation
Anderson AS, Mackison D, Boath C, Steele R. Promoting changes in diet and physical activity in breast and colorectal cancer screening settings: an unexplored opportunity for endorsing healthy behaviors. Cancer Prev Res (Phila). 2013 Mar;6(3):165-72. doi: 10.1158/1940-6207.CAPR-12-0385. Epub 2013 Jan 16.
Results Reference
background
PubMed Identifier
18230739
Citation
Assfalg M, Bertini I, Colangiuli D, Luchinat C, Schafer H, Schutz B, Spraul M. Evidence of different metabolic phenotypes in humans. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1420-4. doi: 10.1073/pnas.0705685105. Epub 2008 Jan 29.
Results Reference
background
PubMed Identifier
22903273
Citation
Steindorf K, Ritte R, Eomois PP, Lukanova A, Tjonneland A, Johnsen NF, Overvad K, Ostergaard JN, Clavel-Chapelon F, Fournier A, Dossus L, Teucher B, Rohrmann S, Boeing H, Wientzek A, Trichopoulou A, Karapetyan T, Trichopoulos D, Masala G, Berrino F, Mattiello A, Tumino R, Ricceri F, Quiros JR, Travier N, Sanchez MJ, Navarro C, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Duijnhoven F, Monninkhof E, May AM, Khaw KT, Wareham N, Key TJ, Travis RC, Borch KB, Sund M, Andersson A, Fedirko V, Rinaldi S, Romieu I, Wahrendorf J, Riboli E, Kaaks R. Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition. Int J Cancer. 2013 Apr 1;132(7):1667-78. doi: 10.1002/ijc.27778. Epub 2012 Sep 14.
Results Reference
background
Links:
URL
http://apps.who.int/iris/bitstream/10665/67447/1/WHO_NMH_NPH_WHD_02.13.pdf
Description
Related Info
Learn more about this trial
STI.VI. Study: How to Improve Lifestyles in Screening Contexts
We'll reach out to this number within 24 hrs